Sansure Biotech Inc. Class ASSE: 688289

Announcement on Voluntary Disclosure of Clinical Trial Approval for New Indications of a Product of a Holding Subsidiary

· Issued by Sansure Biotech Inc. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure of Clinical Trial Approval for New Indications of a Product of a Holding Subsidiary

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis